Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 275 (TMEM275) is a 177-amino acid protein containing two highly conserved alpha-helical transmembrane domains, predicted to insert into the plasma membrane or endoplasmic reticulum membrane. The precise biological function of TMEM275 remains unknown, with no experimentally validated molecular function or specific disease linkage. Expression has been detected in fetal brain, testis, prostate, thyroid, and ovaries, suggesting possible tissue-specificity, but no functional or mechanistic insights are available. TMEM275 is not currently recognized as a therapeutic target, lacks known endogenous ligands or interacting drugs, and is classified as an uncharacterized or “other” transmembrane protein
Null (no drugs target TMEM275)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 275 (TMEM275).